New research report offers a comprehensive analysis of the “Global Market Study on Biosimulation: North America to Dominate the Market in Terms of Revenue During the Forecast Period (2017 - 2022)” The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market.
The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, growing at a CAGR of 15.9%. Factors such as the increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of this ... Read more